SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-194403
Filing Date
2020-07-17
Accepted
2020-07-17 08:18:02
Documents
15
Period of Report
2020-07-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d20373d8k.htm   iXBRL 8-K 34708
2 EX-1.1 d20373dex11.htm EX-1.1 176938
3 EX-5.1 d20373dex51.htm EX-5.1 7379
7 GRAPHIC g20373dsp49.jpg GRAPHIC 3196
  Complete submission text file 0001193125-20-194403.txt   396343

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cytk-20200716.xsd EX-101.SCH 3069
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cytk-20200716_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cytk-20200716_pre.xml EX-101.PRE 10952
8 EXTRACTED XBRL INSTANCE DOCUMENT d20373d8k_htm.xml XML 3279
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 201032800
SIC: 2834 Pharmaceutical Preparations